China's regulatory change toward genome-edited crops

Fei Yang; Kaili Zheng; Yu Yao

doi:10.1016/j.tibtech.2023.12.008

China's regulatory change toward genome-edited crops

Trends Biotechnol. 2023 Dec 30:S0167-7799(23)00347-5. doi: 10.1016/j.tibtech.2023.12.008. Online ahead of print.

Authors

Fei Yang¹, Kaili Zheng¹, Yu Yao²

Affiliations

¹ School of Law, China Jiliang University, 310018 Hangzhou, China.
² School of Law, China Jiliang University, 310018 Hangzhou, China. Electronic address: yaoyusch420@gmail.com.

PMID: 38160083
DOI: 10.1016/j.tibtech.2023.12.008

Abstract

China's newly issued genome-edited crop safety assessment guidelines do not entirely deviate from the existing genetically modified regulatory regimes. However, there is an urgent need to reform the genome-edited regulatory framework based on scientific values and a novel regulatory philosophy that balances diverse values to enhance public trust.

Keywords: CRISPR-CAS; biotechnology regulation; gene editing; genome editing; new breeding techniques.